The involvement of these proteins implicates altered kinase activity in PD pathophysiology, as kinase inhibitors were recently found to prevent and reverse mutated LRRK2-induced dopaminergic-specific behavioral deficits and DAergic neurodegeneration in C. elegans [156]. The gene discussed is LRRK2; the disease is Parkinson disease.